Shattuck Labs (STTK) Revenue (2019 - 2025)
Shattuck Labs (STTK) reported Revenue of $1.0 million for Q3 2025, down 66.63% year-over-year from $3.0 million in Q3 2024, and down 66.63% on a QoQ basis from $3.0 million in Q3 2024.
Shattuck Labs (STTK) has 7 years of Revenue data on file, last reported at $1.0 million in Q3 2025.
- Quarterly Revenue fell 66.63% year-over-year to $1.0 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $1.0 million (down 78.29% YoY) and the FY2025 annual result came in at $1.0 million, down 82.52% from the prior year.
- Revenue declined to $1.0 million in Q3 2025 per STTK's latest filing, from $3.0 million in the prior quarter.
- Across five years, Revenue topped out at $30.0 million in Q4 2021 and bottomed at $50000.0 in Q2 2022.
- The 5-year median for Revenue is $1.0 million (2025), against an average of $3.2 million.
- The widest annual swing landed in 2021, when Revenue surged 2132.19%; it then sank 98.82% in 2022.
- Tracing STTK's Revenue over 5 years: stood at $30.0 million in 2021, then tumbled by 98.7% to $390000.0 in 2022, then jumped by 83.08% to $714000.0 in 2023, then jumped by 319.75% to $3.0 million in 2024, then slumped by 66.63% to $1.0 million in 2025.
- Per Business Quant, the three latest STTK Revenue figures stand at $1.0 million (Q3 2025), $3.0 million (Q3 2024), and $1.6 million (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Shattuck Labs | 667.80 Mn | 667.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 714,000.00 |
| Sep 30, 2023 | 686,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 390,000.00 |
| Sep 30, 2022 | 212,000.00 |
| Jun 30, 2022 | 50,000.00 |
| Dec 31, 2021 | 29.96 Mn |
| Sep 30, 2021 | 1.90 Mn |
| Jun 30, 2021 | 4.23 Mn |
| Mar 31, 2021 | 2.27 Mn |
| Dec 31, 2020 | 1.34 Mn |
| Sep 30, 2020 | 2.44 Mn |
| Jun 30, 2020 | 3.18 Mn |
| Mar 31, 2020 | 2.98 Mn |
| Dec 31, 2019 | 2.82 Mn |
| Sep 30, 2019 | 1.78 Mn |